<DOC>
	<DOCNO>NCT00357357</DOCNO>
	<brief_summary>The purpose Phase II study evaluate safety tolerability HF 0220 patient Alzheimer 's disease compare placebo ( inactive substance ) . The study also validate biochemical marker appropriate clinical end-points assess suitability choose dose level future clinical study .</brief_summary>
	<brief_title>European Study HF0220 Mild Moderate Alzheimer 's Disease Patients</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>RECRUITMENT OF PARTICIPANTS IS PERFORMED ONLY BY STUDY SITES INCLUSION CRITERIA : Participants must meet follow inclusion criterion eligible . Male Female ( age 55 year ) . Females must nonchildbearing potential . Male patient female partner childbearing potential use effective contraception duration Study . A diagnosis probable Alzheimer 's disease establish accordance National Institute Neurological Communicative Disorders Stroke /Alzheimer 's disease Related Disorders Association ( NINCDSADRDA ) classification . Severity dementia mild moderate assess MiniMental State Examination ( MMSE ) score 1224 . Patients must live community live least daily visit responsible carer . The carer capable assist patient 's medication , prepared attend patient assessment . Written consent obtain patient responsible carer . EXCLUSION CRITERIA Patients eligible participate study meet follow criterion : Primary , secondary pseudodementias probable Alzheimer 's disease . Clinically significant and/or uncontrolled condition significant medical disease . If take medication symptom dementia , patient must stable therapy take minimum 3 month prior enrolment . Treatment within previous 3 month drug know well define potential hepatotoxicity . Nonsteroidal steroidal antiinflammatory agent . However , patient stable low dose aspirin ( upto 300mg/day ) least 3 month prior enrolment eligible . Taking antioxidant supplement . Active smoker tobacco . Considered malnourished ( body mass index &lt; 19 ) . Patients lumbar puncture contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Alzheimer 's disease</keyword>
</DOC>